Elizabeth Ashlynn FalconerSenior AssociateNelson MullinsWebsitewww.nelsonmullins.comOrganization ProfileFull ProfileConnectEmail404-322-6265 Professional Biography Elizabeth focuses her practice in the areas of pharmaceutical and medical device defense, commercial litigation, transportation, and product liability. More Legal and Business Bylines From Elizabeth Ashlynn Falconer FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle - (Posted On Thursday, March 21, 2024) Current Legal Analysis CFPB Study Finds Differential Treatment in the Small Business Lending Market by: A.J. S. Dhaliwal , Mehul N. Madia CNIPA 2025 Closure Dates by: Aaron Wininger Cancel Culture: New Requirements for Automatic Renewal and Other Negative Option Offers by: Kyle R. Dull , Julia B. Jacobson CFPB Commercial Lending Study Finds Differential Treatment in the Small Business Lending Market by: A.J. S. Dhaliwal , Mehul N. Madia 2024 U.S. Election Implications by: Robert C. Jones , Robert Mangas Texas Federal Court Vacates 2024 FLSA Salary Basis Rule, Reversing Prior July Increase by: Labor and Employment at Foley & Lardner Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 19 2024 Global Antitrust Update | Webinar Series – Winter 2024 Nov 20 2024 Top Tips for Employers – A New Direction for Immigration? The Impact of the Presidential Election Nov 20 2024 Earned Sick Time Act Discussion Nov 20 2024 OSHA 30/30 - November 20, 2024 Nov 20 2024 Wages in an Hour Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Print
